E 12 Pill: orange, oval, 20mm
The pill with imprint E 12 (Orange, Oval, 20mm) has been identified as Levetiracetam 750 mg and is used for Seizures, and Epilepsy. It belongs to the drug class pyrrolidine anticonvulsants and is not a controlled substance.
Images for E 12
Levetiracetam
- Imprint
- E 12
- Strength
- 750 mg
- Color
- Orange
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
corn starch,
silicon dioxide,
povidone k30,
magnesium silicate,
magnesium stearate,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 4000,
water,
FD&C Yellow No. 6,
FD&C Blue No. 2,
ferric oxide red
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 16714-0356 | NorthStar Rx LLC |
| 63739-0787 | McKesson Packaging Services |
| 65862-0247 | Aurobindo Pharma Limited |
| 68084-0882 | Amerisource Health Services |
Related images for "E 12"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (434)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
- Levetiracetam Injection
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.